Tumour necrosis factor in renal transplantation
McLaughlin, P.J.; Aikawa, A.A.; Davies, H.M.; Bakran, A.; Sells, R.A.; Johnson, P.M.
Transplantation Proceedings 23(1 Part 2): 1289-1290
1991
ISSN/ISBN: 0041-1345 PMID: 1989215 Document Number: 379641
Document emailed within 1 workday
Related Documents
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413
Hasan, U. 2006: Tumour necrosis factor inhibitors--what we need to know New Zealand Medical Journal 119(1246): U2336
Jayasinghe, K.S.; Ariaratnam, A. 1994: Tumour necrosis factor (TNF) in Russell's viper envenomation Ceylon Medical Journal 39(2): 112-113
Campbell, D.A.; Li Kam Wa, E.; Britton, J.; Holgate, S.T.; Markham, A.F.; Morrison, J.F. 1996: Polymorphism at the tumour necrosis factor locus and asthma Monographs in Allergy 33: 125-137
Cohen, J.; Exley, A.R. 1993: Treatment of septic shock with antibodies to tumour necrosis factor Schweizerische Medizinische Wochenschrift 123(11): 492-496
O'Reilly, D.A.; Dunlop, S.; Sargen, K.; Demaine, A.; Wilkinson, S.; Kingsnorth, A.N. 2006: Tumour necrosis factor microsatellite haplotypes are associated with chronic pancreatitis Jop: Journal of the Pancreas 7(1): 14-26
Jackson, G.D.; Dai, Y.; Fung, C.; Hansen, P.G. 1995: Tumour necrosis factor alpha--a constitutive protein of bile Advances in Experimental Medicine and Biology 371b: 1083-1086
Ip, K.; Hartley, L.; Solanki, K.; White, D. 2015: Retention on anti-tumour necrosis factor therapy: the Waikato experience New Zealand Medical Journal 128(1415): 34-40
Fukui, T.; Yamagishi, J.; Furutani, Y.; Notake, M.; Yamayoshi, M.; Nomura, H.; Yamada, M.; Nakamura, S. 1985: Efficient production of a human tumour necrosis factor in Escherichia coli Nucleic Acids Symposium Series 1985(16): 273-276
An, H-Jin.; Seo, M-Jun.; Choi, I-Young.; Park, R-Kil.; Jeong, S.; Lee, J-Young.; Kim, H-Min.; Um, J-Young.; Hong, S-Heon. 2008: Induction of nitric oxide & tumour necrosis factor-alpha by Psoralea corylifolia Indian Journal of Medical Research 128(6): 752-758
Pennica, D.; Nedwin, G.E.; Hayflick, J.S.; Seeburg, P.H.; Derynck, R.; Palladino, M.A.; Kohr, W.J.; Aggarwal, B.B.; Goeddel, D.V. 1984: Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin Nature 312(5996): 724-729
Naylor, M.S.; Malik, S.T.; Stamp, G.W.; Jobling, T.; Balkwill, F.R. 1990: In situ detection of tumour necrosis factor in human ovarian cancer specimens European Journal of Cancer 26(10): 1027-1030
Munoz, C.; Olivares, M.; Schlesinger, L.; Lopez, M.; Letelier, A. 1994: Increased in vitro tumour necrosis factor-alpha production in iron deficiency anemia European Cytokine Network 5(4): 401-404
Pang, X.P.; Hershman, J.M.; Smith, V.; Pekary, A.E.; Sugawara, M. 1990: The mechanism of action of tumour necrosis factor-alpha and interleukin 1 on FRTL-5 rat thyroid cells Acta Endocrinologica 123(2): 203-210
Hofmann, S.; Grasberger, H.; Jung, P.; Bidlingmaier, M.; Vlotides, J.; Janssen, O.E.; Landgraf, R. 2002: The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression European Journal of Medical Research 7(4): 171-176
Rahier, J.F.; Lion, L.; Dewit, O.; Lambert, M. 2005: Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy Acta Gastro-Enterologica Belgica 68(3): 376-379
Yoshida, A.; Kohchi, C.; Inagawa, H.; Nishizawa, T.; Hori, H.; Soma, G.-I. 2006: A soluble 17 kDa tumour necrosis factor (TNF) mutein, TNF-SAM2, with membrane-bound TNF-like biological characteristics Anticancer Research 26(6a): 4003-4007